Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Artisan Partners Limited Partnership Grows Stock Position in Insmed, Inc. $INSM
03:16am, Friday, 27'th Feb 2026
Artisan Partners Limited Partnership grew its position in shares of Insmed, Inc. (NASDAQ: INSM) by 49.0% during the third quarter, according to its most recent disclosure with the Securities and Excha
Artisan Global Discovery Fund Q4 2025 Winners, Laggards, Buys & Sells
07:30am, Thursday, 26'th Feb 2026
The portfolio generated strong absolute returns in Q4 and 2025 but trailed the MSCI All Country World Small Mid Index over each period. Stock selection in health care was the strongest contributor to
Insmed (NASDAQ:INSM) CEO William Lewis Sells 10,699 Shares
04:48am, Tuesday, 24'th Feb 2026
Insmed, Inc. (NASDAQ: INSM - Get Free Report) CEO William Lewis sold 10,699 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price
Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View
11:21am, Friday, 20'th Feb 2026
INSM shares jump 7% as Brinsupri sales surge and 2026 outlook calls for at least $1B, despite a wider Q4 loss and rising expenses.
Wall Street Analysts Think Insmed (INSM) Could Surge 33.6%: Read This Before Placing a Bet
10:55am, Friday, 20'th Feb 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 33.6% in Insmed (INSM). While the effectiveness of this highly sought-after metric is questionable, the positiv
Insmed, Inc. $INSM Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.
06:18am, Friday, 20'th Feb 2026
BNP PARIBAS ASSET MANAGEMENT Holding S.A. cut its holdings in shares of Insmed, Inc. (NASDAQ: INSM) by 34.2% in the third quarter, according to its most recent filing with the Securities and Exchange
Insmed Incorporated (INSM) Q4 2025 Earnings Call Transcript
12:55pm, Thursday, 19'th Feb 2026
Insmed Incorporated (INSM) Q4 2025 Earnings Call Transcript
Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 19'th Feb 2026
The headline numbers for Insmed (INSM) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates
09:10am, Thursday, 19'th Feb 2026
Insmed (INSM) came out with a quarterly loss of $1.54 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $1.32 per share a year ago.
Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
07:00am, Thursday, 19'th Feb 2026
—Company Expects Full-Year 2026 BRINSUPRI® (brensocatib) Revenues to Be at Least $1 Billion; Reiterates Full-Year 2026 ARIKAYCE ® (amikacin liposome inhalation suspension) Revenue Guidance of $4
What to Expect From These Drug/Biotech Players This Earnings Season?
03:16pm, Monday, 16'th Feb 2026
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.
Insmed To Present at March 2026 Investor Conferences
07:00am, Friday, 13'th Feb 2026
BRIDGEWATER, N.J., Feb. 13, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:00am, Thursday, 12'th Feb 2026
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wellington Shields & Co. LLC Acquires New Holdings in Insmed, Inc. $INSM
04:42am, Saturday, 07'th Feb 2026
Wellington Shields and Co. LLC bought a new stake in Insmed, Inc. (NASDAQ: INSM) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026
07:00am, Thursday, 05'th Feb 2026
BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform
